Examination of efficacy and safety treated by denosumab or zoledronate in glucocorticoid-induced osteoporosis
Not Applicable
Recruiting
- Conditions
- Glucocorticoid-induced osteoporosis
- Registration Number
- JPRN-UMIN000035844
- Lead Sponsor
- Dept. of Orthopaedic Surgery Shinshu University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1 Patients who have taken denosumab or zoledronate before 2 Patients who are allergic to denosumab or zoledronate 3 Pregnant or breast-feeding patients 4 Renal failure (Ccr is less than 35 mL/min) 5 Dehydrated state 6 Hypocalcemia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method